Offers a comprehensive view of one of most important efforts in the research of drugs against the SARS-CoV-2 virus
Shows the different efforts from a multidisciplinary point of view
Provides an in-depth explanation of one of the most important cases of Urgent Computing
Part of the book series: SpringerBriefs in Applied Sciences and Technology (BRIEFSAPPLSCIENCES)
Buy it now
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, access via your institution.
Table of contents (10 chapters)
About this book
This book highlights the different aspects of the research project “E4C Horizon 2020 European Project” aimed at fighting the coronavirus by combining the best supercomputing resources and artificial intelligence with state-of-the-art experimental facilities up through clinical validation.
Coronavirus disease has become an important public issue across the globe since December 2019. There is an urgent need to develop potent anti-COVID-19 agents for the prevention of the outbreak and stop viral infections.
To this aim, a public–private consortium composed by European and national infrastructures, center of excellence, universities, and a pharmaceutical company started the E4C Horizon 2020 European
Project: Its core idea was to use the EXaSCale smArt pLatform Against paThogEns (EXSCALATE) supercomputing platform for a process known as “drug repurposing”, namely to identify the most promising safe in man drugs for immediate treatment of the already infected population and then novel pan-coronavirus inhibitors to address future emergencies.
This ambitious goal exploited a “chemical library” of 500 billion molecules, thanks to a processing capacity of more than 3 million molecules per second, made available by the computing power of the EXSCALATE platform.
- Exascale Computing
- drug discovery
- drug research against the Sars-Cov2
- LIGATE project
- molecule drug active against coronavirus
- drug repurposing
- computational modeling
Editors and Affiliations
CHELONIA SA, Lugano, Switzerland
About the editors
Gabriella Bernardi is a freelance journalist and writer. She graduated in physics from the University of Turin and also holds a master’s degree in Journalism and Science Communication. She was awarded the Voltolino Prize for scientific journalism by the Italian Union of Scientific Journalists (UGIS). Since 2008, she has been a member of the European Union of Science Journalists’ Association (EUSJA). She is a member of the International Astronomical Union (IAU); she also serves on the Executive Committee Working Group “Women in Astronomy”. She has published in several newspapers and magazines that specialize in the popularization of astronomy and is the author of six astronomy books, three of which are in English and published by Springer. She collaborates with Chelonia SA as the social media manager for the Exscalate4CoV and LIGATE projects.
Book Title: Exscalate4CoV
Book Subtitle: High-Performance Computing for COVID Drug Discovery
Editors: Silvano Coletti, Gabriella Bernardi
Series Title: SpringerBriefs in Applied Sciences and Technology
Publisher: Springer Cham
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
Softcover ISBN: 978-3-031-30690-7Published: 03 May 2023
eBook ISBN: 978-3-031-30691-4Published: 02 May 2023
Series ISSN: 2191-530X
Series E-ISSN: 2191-5318
Edition Number: 1
Number of Pages: XVII, 86
Number of Illustrations: 2 b/w illustrations, 17 illustrations in colour